This afternoon we watched Cigna rise 2.9% to a price of $263.71 per share. The Large-Cap Medical Specialities company is now trading -20.8% below its average target price of $332.96. Analysts have set target prices ranging from $270.0 to $378.0 per share for Cigna, and have given the stock an average rating of buy.
Cigna's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.9%. The stock's short ratio is 2.63. The company's insiders own 1.59% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 89.8%. In conclusion, we believe there is positive market sentiment regarding Cigna.
Institutions Invested in Cigna
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Vanguard Group Inc | 10% | 25,726,681 | $6,784,511,585 |
| 2025-06-30 | Blackrock Inc. | 8% | 22,326,264 | $5,887,770,628 |
| 2025-06-30 | State Street Corporation | 5% | 12,260,613 | $3,233,307,512 |
| 2025-06-30 | FMR, LLC | 4% | 11,165,790 | $2,944,586,268 |
| 2025-09-30 | Massachusetts Financial Services Co. | 4% | 10,901,749 | $2,874,954,697 |
| 2025-06-30 | Price (T.Rowe) Associates Inc | 4% | 10,293,832 | $2,714,637,868 |
| 2025-06-30 | Dodge & Cox Inc | 3% | 8,950,610 | $2,360,410,083 |
| 2025-06-30 | Sanders Capital, LLC | 3% | 7,793,018 | $2,055,135,713 |
| 2025-06-30 | JPMORGAN CHASE & CO | 2% | 6,462,953 | $1,704,377,626 |
| 2025-06-30 | Geode Capital Management, LLC | 2% | 5,963,102 | $1,572,559,422 |
